drugset / Trial / NCT07713186

Azithromycin in Atopic Dermatitis

NCT07713186

Phase 4 Not yet recruiting 40 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

The study will evaluate the role of adding azithromycin to topical treatment in patients with mild to moderate atopic dermatitis

Timeline

Start
2026-08-01
Primary completion
2027-01
Completion
2027-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule
Background Betamethasone Other / unclassified Topical
Background Tacrolimus Small molecule Topical

Indications